Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relistor vs Movantik for Opioid-Induced Constipation in the ED
NCT03523520Phase 4Completed
- Sponsor
- University of Missouri
- Start
- Dec 2020
- Primary completion
- Mar 2023
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of methylnaltrexone, naloxegol in opioid-induced constipation (OIC), sponsored by University of Missouri. Started Dec 2020; status: completed.
02
Drugs
methylnaltrexonenaloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT03523520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523520.